Journal of Cell Science, Vol 113, Issue 23 4221-4230, Copyright © 2000 by Company of Biologists

JOURNAL ARTICLES

p125 focal adhesion kinase promotes malignant astrocytoma cell proliferation in vivo

D Wang, JR Grammer, CS Cobbs, JE Stewart, Z Liu, R Rhoden, TP Hecker, Q Ding and CL Gladson
The Department of Pathology, Division of Neuropathology and The Department of Surgery, Division of Neurosurgery, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.

p125 focal adhesion kinase (p125FAK) is a cytoplasmic tyrosine kinase that is activated upon engagement of integrin cell adhesion receptors, and initiates several signaling events that modulate cell function in vitro. To determine the biologic role of p125FAK in malignant astrocytic tumor cells, U-251MG human malignant astrocytoma cells were stably transfected with p125FAK cDNA using the TET-ON system, and stable clones isolated that exhibited an estimated 5- or 20-fold increase in p125FAK expression on administration of 0.1 or 2.0 microg/ml doxycycline, respectively. In vitro studies demonstrated that induction of p125FAK resulted in a 2- to 3-fold increase in cell migration, increased p130CAS phosphorylation, localization of exogenous p125FAK to focal adhesions, and a 2-fold increase in soft agar growth. To determine the role of p125FAK in vivo, clones were injected stereotactically into the brains of scid mice. A 4.5-fold estimated increase in p125FAK expression was induced by administration of doxycycline in the drinking water. Analysis of xenograft brains demonstrated that, upon induction of p125FAK, there was a 1.6- to 2.8-fold increase in tumor cell number, and an increase in mAb PCNA-labeling of tumor cells in the absence of a change in the apoptotic index. Compared to normal brain, the expression of p125FAK was elevated in malignant astrocytic tumor biopsies from patient samples. These data demonstrate for the first time that p125FAK promotes tumor cell proliferation in vivo, and that the underlying mechanism is not associated with a reduction in apoptosis.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				P. P. Provenzano, D. R. Inman, K. W. Eliceiri, H. E. Beggs, and P. J. Keely Mammary Epithelial-Specific Disruption of Focal Adhesion Kinase Retards Tumor Formation and Metastasis in a Transgenic Mouse Model of Human Breast Cancer Am. J. Pathol., November 1, 2008; 173(5): 1551 - 1565. [Abstract] [Full Text] [PDF]

				X. Cai, D. Lietha, D. F. Ceccarelli, A. V. Karginov, Z. Rajfur, K. Jacobson, K. M. Hahn, M. J. Eck, and M. D. Schaller Spatial and Temporal Regulation of Focal Adhesion Kinase Activity in Living Cells Mol. Cell. Biol., January 1, 2008; 28(1): 201 - 214. [Abstract] [Full Text] [PDF]

				C. Y. Fears, C. L. Gladson, and A. Woods Syndecan-2 Is Expressed in the Microvasculature of Gliomas and Regulates Angiogenic Processes in Microvascular Endothelial Cells J. Biol. Chem., May 26, 2006; 281(21): 14533 - 14536. [Abstract] [Full Text] [PDF]

				B. Gabriel, A. zur Hausen, E. Stickeler, C. Dietz, G. Gitsch, D.-C. Fischer, J. Bouda, C. Tempfer, and A. Hasenburg Weak Expression of Focal Adhesion Kinase (pp125FAK) in Patients with Cervical Cancer Is Associated with Poor Disease Outcome Clin. Cancer Res., April 15, 2006; 12(8): 2476 - 2483. [Abstract] [Full Text] [PDF]

				H. Park, I. Han, H. J. Kwon, and E.-S. Oh Focal Adhesion Kinase Regulates Syndecan-2-Mediated Tumorigenic Activity of HT1080 Fibrosarcoma Cells Cancer Res., November 1, 2005; 65(21): 9899 - 9905. [Abstract] [Full Text] [PDF]

				C. Y. Fears, J. R. Grammer, J. E. Stewart Jr., D. S. Annis, D. F. Mosher, P. Bornstein, and C. L. Gladson Low-Density Lipoprotein Receptor-Related Protein Contributes to the Antiangiogenic Activity of Thrombospondin-2 in a Murine Glioma Model Cancer Res., October 15, 2005; 65(20): 9338 - 9346. [Abstract] [Full Text] [PDF]

				M. J. van Nimwegen, S. Verkoeijen, L. van Buren, D. Burg, and B. van de Water Requirement for Focal Adhesion Kinase in the Early Phase of Mammary Adenocarcinoma Lung Metastasis Formation Cancer Res., June 1, 2005; 65(11): 4698 - 4706. [Abstract] [Full Text] [PDF]

				Q. Ding, J. R. Grammer, M. A. Nelson, J.-L. Guan, J. E. Stewart Jr., and C. L. Gladson p27Kip1 and Cyclin D1 Are Necessary for Focal Adhesion Kinase Regulation of Cell Cycle Progression in Glioblastoma Cells Propagated in Vitro and in Vivo in the Scid Mouse Brain J. Biol. Chem., February 25, 2005; 280(8): 6802 - 6815. [Abstract] [Full Text] [PDF]

				T. Iwahara, T. Akagi, Y. Fujitsuka, and H. Hanafusa CrkII regulates focal adhesion kinase activation by making a complex with Crk-associated substrate, p130Cas PNAS, December 21, 2004; 101(51): 17693 - 17698. [Abstract] [Full Text] [PDF]

				Y. Lim, I. Han, J. Jeon, H. Park, Y.-Y. Bahk, and E.-S. Oh Phosphorylation of Focal Adhesion Kinase at Tyrosine 861 Is Crucial for Ras Transformation of Fibroblasts J. Biol. Chem., July 9, 2004; 279(28): 29060 - 29065. [Abstract] [Full Text] [PDF]

				K. Moissoglu and I. H. Gelman v-Src Rescues Actin-based Cytoskeletal Architecture and Cell Motility and Induces Enhanced Anchorage Independence during Oncogenic Transformation of Focal Adhesion Kinase-null Fibroblasts J. Biol. Chem., November 28, 2003; 278(48): 47946 - 47959. [Abstract] [Full Text] [PDF]

				H. Haskell, M. Natarajan, T. P. Hecker, Q. Ding, J. Stewart Jr., J. R. Grammer, and C. L. Gladson Focal Adhesion Kinase Is Expressed in the Angiogenic Blood Vessels of Malignant Astrocytic Tumors in Vivo and Promotes Capillary Tube Formation of Brain Microvascular Endothelial Cells Clin. Cancer Res., June 1, 2003; 9(6): 2157 - 2165. [Abstract] [Full Text] [PDF]

				J. T. Parsons Focal adhesion kinase: the first ten years J. Cell Sci., April 15, 2003; 116(8): 1409 - 1416. [Abstract] [Full Text] [PDF]

				Q. Ding, J. Stewart Jr., C. W. Prince, P.-L. Chang, M. Trikha, X. Han, J. R. Grammer, and C. L. Gladson Promotion of Malignant Astrocytoma Cell Migration by Osteopontin Expressed in the Normal Brain: Differences in Integrin Signaling during Cell Adhesion to Osteopontin Versus Vitronectin Cancer Res., September 15, 2002; 62(18): 5336 - 5343. [Abstract] [Full Text] [PDF]

				T. P. Hecker, J. R. Grammer, G. Y. Gillespie, J. Stewart Jr., and C. L. Gladson Focal Adhesion Kinase Enhances Signaling through the Shc/Extracellular Signal-regulated Kinase Pathway in Anaplastic Astrocytoma Tumor Biopsy Samples Cancer Res., May 1, 2002; 62(9): 2699 - 2707. [Abstract] [Full Text] [PDF]

				J. Zhao, R. Pestell, and J.-L. Guan Transcriptional Activation of Cyclin D1 Promoter by FAK Contributes to Cell Cycle Progression Mol. Biol. Cell, December 1, 2001; 12(12): 4066 - 4077. [Abstract] [Full Text] [PDF]

				C. R. Hauck, D. J. Sieg, D. A. Hsia, J. C. Loftus, W. A. Gaarde, B. P. Monia, and D. D. Schlaepfer Inhibition of Focal Adhesion Kinase Expression or Activity Disrupts Epidermal Growth Factor-stimulated Signaling Promoting the Migration of Invasive Human Carcinoma Cells Cancer Res., October 1, 2001; 61(19): 7079 - 7090. [Abstract] [Full Text] [PDF]

				D. Ilic, O. Genbacev, F. Jin, E. Caceres, E. A. C. Almeida, V. Bellingard-Dubouchaud, E. M. Schaefer, C. H. Damsky, and S. J. Fisher Plasma Membrane-Associated pY397FAK Is a Marker of Cytotrophoblast Invasion in Vivo and in Vitro Am. J. Pathol., July 1, 2001; 159(1): 93 - 108. [Abstract] [Full Text] [PDF]